Navigation Links
CellThera and WPI advance in regeneration study
Date:3/23/2009

WORCESTER, Mass. CellThera, a biotechnology company located in Worcester Polytechnic Institute's Life Sciences and Bioengineering Center at Gateway Park, has received a contract from the U.S. Defense Advanced Research Projects Agency (DARPA) to extend its research program in tissue regeneration. Under the terms of the contract, CellThera, which is part of WPI's Bioengineering Institute (BEI), and the university will continue their joint efforts aimed at restoring tissues damaged or lost due to traumatic injury.

"We are very pleased to be moving into the next phase of this work," said Raymond Page, PhD, research assistant professor in BEI and WPI's Department of Biology and Biotechnology, who serves as the principal investigator for WPI's portion of the program. "The collaboration between WPI and CellThera continues to grow and show progress. We look forward to tackling the challenges ahead."

DARPA, which serves as the research and development wing of the U.S. Defense Department, awarded CellThera a one-year $570,000 contract, with an option to extend for a second year, to fund studies aimed at regenerating mammalian muscle tissue. CellThera, in turn, subcontracted with WPI for certain elements of the research. This joint research model was established in 2006, when DARPA funded the first phase of the tissue regeneration program. In that initial phase of the research, the CellThera/WPI team, working in conjunction with colleagues at Tulane University, succeeded in reprogramming mouse and human skin cells to act more like stem cells, able to form the early structures needed to begin the process of re-growing lost tissues.

In the new phase of the program, the CellThera/WPI team will try to reprogram and engineer cells to replace damaged skeletal muscle and to restore the normal function of that muscle. Joining the effort for the new phase of this work will be George Pins, PhD, associate professor of biomedical engineering at WPI, who has pioneered novel cell-delivery strategies that will be useful for the project. The new phase also involves collaboration with the clinical research team led by Raymond Dunn, MD, professor of surgery and cell biology at the University of Massachusetts Medical School and chief of plastic and reconstructive surgery at UMass Memorial Medical Center.

"This new award not only validates the important work CellThera and WPI are doing in the area of regenerative medicine, but by bringing together basic science, engineering and the clinical expertise of UMass, along with the commercial strength in the Worcester region, this work will help push the science closer to the clinic and closer to helping people recover from devastating injuries," said Eric W. Overstrm, PhD, professor and head of WPI's Department of Biology and Biotechnology.

The long-range goal of the DARPA program is to find ways to harness the body's natural regenerative abilities to heal wounds that involve bone, muscle, nerves, and soft tissue. The impetus for the program is to develop new therapies for soldiers who return home from war with major injuries. If successful, however, the science will have a broad range of civilian applications, as well. "Translating basic science advances into products and technologies that can improve people's lives is BEI's core mission," said BEI Director W. Grant McGimpsey, PhD. "So it's exciting to see the talented teams at CellThera, WPI and UMass Medical School working together seamlessly to advance this program."


'/>"/>

Contact: Michael Cohen
mcohen@wpi.edu
508-868-4778
Worcester Polytechnic Institute
Source:Eurekalert

Related biology news :

1. U.S. Navy Awards Lockheed Martin Six-year Contract Worth Up to $72 Million for Advanced Display Systems Support
2. Salient Stills Notches Significant Advances in Profitability, Diversity of Sales and Customers, and Video Forensics Technology in 2008
3. Iowa Power Fund advances researcher’s long quest for efficient solar power
4. Singapore research organisations team up to advance drug discovery using brain tumor stem cells
5. Advancement in tissue engineering promotes oral wound healing
6. Evolution and climate change research advances at Rutgers-Camden
7. Developer of advanced computing memory, father of biochemical engineering, and innovative engineering educators win highest engineering honors of 2009
8. 13 UCR faculty members recognized by American Association for the Advancement of Science
9. American Association for the Advancement of Science honors four Iowa Staters
10. Researchers advance knowledge of little nano-machines in our body
11. TECNALIA investigates advanced biomaterials to make more reliable and hardwearing medical implants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2016)... , 19 de diciembre de 2016  Mosaic Biomedicals SL ... desarrollo acelerado de MSC-1, un anticuerpo humanizado que se espera comenzar ... 2017, con múltiples sitios previstos a lo largo de Europa y ... MSC-1 es ... inhibidor de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa en ...
(Date:12/15/2016)...   WaferGen Bio-systems, Inc. (NASDAQ: ... today that on December 13, 2016, it received a ... Stock Market LLC which acknowledged that, as of December ... stock had been at $1.00 or greater for ten ... Listing Rule 5550(a)(2) of the Nasdaq Stock Market. ...
(Date:12/12/2016)...  Researchers at Trinity College, Dublin, are opening ... the material with Silly Putty. The mixture (known as ... to sense pulse, blood pressure, respiration, and even ... The research team,s findings were published Thursday ... http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... 2017 Interpace Diagnostics Group, Inc. (NASDAQ: ... clinically useful molecular diagnostic tests and pathology services, ... securities purchase agreement with three  institutional investors to ... stock in a registered direct offering.  In a ... sell to the same investors warrants to purchase ...
(Date:1/21/2017)... , Jan. 20, 2017 Aratana Therapeutics, ... company focused on the licensing, development and commercialization of ... Pharm,s Best Company in North America ... the award based on the FDA approval ... (grapiprant tablets), ENTYCE ® (capromorelin oral solution) and ...
(Date:1/20/2017)... ... , ... The two newest companies to join the University City Science Center’s ... from The Wistar Institute, and Sanguis, launched by a trio of students from the ... Vironika is developing a treatment for a chronic viral infection and its associated diseases, ...
(Date:1/20/2017)... Ginkgo Bioworks, the organism company, announced ... the synthesis and assembly of DNA. The acquisition ... synthetic DNA into Ginkgo,s automated organism engineering foundries, ... of new organism designs for application across a ... founded to significantly increase the world,s capacity to ...
Breaking Biology Technology: